Trials / Completed
CompletedNCT00952913
Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy Subjects
A Study to Examine The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib When Administered Concomitantly To Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to see if there is an effect on the pharmacokinetics of bosutinib when administered with lansoprazole.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bosutinib | 4 x 100-mg oral tablets, single dose |
| DRUG | Bosutinib | 4 x 100-mg oral tablets, single dose |
| DRUG | Lansoprazole | 2 x 30-mg oral tablets, single daily doses for 2 days |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-10-01
- Completion
- 2009-10-01
- First posted
- 2009-08-06
- Last updated
- 2011-04-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00952913. Inclusion in this directory is not an endorsement.